Additionally, the authors will study the expression of LINC01857 in the serum of pancreatic cancer patients and investigate whether the serum expression level of LINC01857 can be used to distinguish between chemoresistant patients and chemosensitive patients with PDAC in the future. The gene discussed is LINC01857; the disease is familial pancreatic carcinoma.